Compare $ENSC vs $TOVX | Chartloom

Compare

$ENSC vs $TOVX

Ensysce Biosciences Inc · Theriva Biologics Inc

ENSC

Ensysce Biosciences Inc

TOVX

Theriva Biologics Inc

Compare $ENSC vs $TOVX

Comparing Ensysce Biosciences Inc and Theriva Biologics Inc

ENSCEnsysce Biosciences Inc

TOVXTheriva Biologics Inc

ENSCEnsysce Biosciences Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-39.3%

YTD performance

-43.9%

52W performance

-78.6%

FCF yield

-116.0%

TOVXTheriva Biologics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-16.5%

52W performance

-51.8%

FCF yield

-128.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ENSC

TOVX

Detailed metrics comparison

ENSC

Ensysce Biosciences Inc

TOVX

Theriva Biologics Inc

Market Cap

ENSC$8M

TOVX$10M

Enterprise Value

ENSC$7M

TOVX$275K

Price

ENSC$0.53

TOVX$0.22

P/E Ratio

ENSCN/A

TOVXN/A

P/S Ratio

ENSC1.72x

TOVX33.19x

EV/Sales

ENSC1.61x

TOVX0.92x

EV/EBITDA

ENSC0.00x

TOVX0.00x

P/B Ratio

ENSC2.39x

TOVX0.85x

P/FCF Ratio

ENSCN/A

TOVXN/A

EV/FCF

ENSC-0.81x

TOVX-0.02x

PEG Ratio

ENSCN/A

TOVXN/A

Forward P/E (NTM)

ENSCN/A

TOVXN/A

Forward P/S (NTM)

ENSCN/A

TOVXN/A

Revenue (TTM)

ENSC$5M

TOVX$300K

Revenue Growth (YoY)

ENSC-39.3%

TOVXN/A

Forward Rev Growth

ENSC-45.7%

TOVX20375.2%

Gross Margin (TTM)

ENSC0.0%

TOVX71.5%

Operating Margin (TTM)

ENSC0.0%

TOVX0.0%

EBITDA Margin (TTM)

ENSC-197.8%

TOVX-3940.7%

Net Margin (TTM)

ENSC-280.5%

TOVX-4376.0%

FCF Margin (TTM)

ENSC-199.5%

TOVX-4254.7%

Net Income (TTM)

ENSC$-13M

TOVX$-13M

FCF (TTM)

ENSC$-9M

TOVX$-13M

EPS (TTM)

ENSC-$0.97

TOVX-$0.29

ROE (TTM)

ENSC-37496.0%

TOVX-9349.0%

ROA (TTM)

ENSC-32046.0%

TOVX-3269.0%

ROIC (TTM)

ENSC-33277.0%

TOVX-8231.0%

Cash

ENSC$677K

TOVX$11M

Debt

ENSC$197K

TOVX$2M

Net Cash/Debt

ENSC$480K

TOVX$10M

Current Ratio (TTM)

ENSC0.70x

TOVX1.13x

Quick Ratio (TTM)

ENSC0.37x

TOVX1.09x

Debt/Equity (TTM)

ENSC0.10x

TOVX0.14x

Debt/Assets (TTM)

ENSC0.0%

TOVX0.0%

Interest Coverage (TTM)

ENSCN/A

TOVXN/A

Net Debt/EBITDA (TTM)

ENSC0.00x

TOVX0.00x

Beta

ENSC1.10

TOVX1.25

52W Performance

ENSC-78.6%

TOVX-51.8%

YTD Performance

ENSC-43.9%

TOVX-16.5%

% from 52W High

ENSC-80.8%

TOVX-74.8%

% from 52W Low

ENSC129.1%

TOVX35.6%

Asset Turnover (TTM)

ENSC1.14x

TOVX0.01x

FCF Yield (TTM)

ENSC-116.0%

TOVX-128.2%

Earnings Yield (TTM)

ENSC-163.1%

TOVX-131.8%

Dividend Yield (TTM)

ENSCN/A

TOVXN/A

Rule of 40

ENSC-238.8

TOVX-4,254.7

EV/GP/RG

ENSCN/A

TOVX0.00

Ticker research

View ENSC research View TOVX research

Metric	ENSC Ensysce Biosciences Inc	TOVX Theriva Biologics Inc
Market & Valuation
Market Cap	$8M	$10M
Enterprise Value	$7M	$275K
Price	$0.53	$0.22
P/E Ratio	N/A	N/A
P/S Ratio	1.72x	33.19x
EV/Sales	1.61x	0.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.39x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.81x	-0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$300K
Revenue Growth (YoY)	-39.3%	N/A
Forward Rev Growth	-45.7%	20375.2%
Profitability
Gross Margin (TTM)	0.0%	71.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-197.8%	-3940.7%
Net Margin (TTM)	-280.5%	-4376.0%
FCF Margin (TTM)	-199.5%	-4254.7%
Net Income (TTM)	$-13M	$-13M
FCF (TTM)	$-9M	$-13M
EPS (TTM)	-$0.97	-$0.29
ROE (TTM)	-37496.0%	-9349.0%
ROA (TTM)	-32046.0%	-3269.0%
ROIC (TTM)	-33277.0%	-8231.0%
Financial Health
Cash	$677K	$11M
Debt	$197K	$2M
Net Cash/Debt	$480K	$10M
Current Ratio (TTM)	0.70x	1.13x
Quick Ratio (TTM)	0.37x	1.09x
Debt/Equity (TTM)	0.10x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.10	1.25
52W Performance	-78.6%	-51.8%
YTD Performance	-43.9%	-16.5%
% from 52W High	-80.8%	-74.8%
% from 52W Low	129.1%	35.6%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.01x
FCF Yield (TTM)	-116.0%	-128.2%
Earnings Yield (TTM)	-163.1%	-131.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-238.8	-4,254.7
EV/GP/RG	N/A	0.00
Ticker research	View ENSC research	View TOVX research

Valuation

P/S Ratio

ENSC

1.72x

TOVX

33.19x

EV/FCF

ENSC

-0.81x

TOVX

-0.02x

Growth & revenue

Revenue Growth TTM

ENSC

-39.3%

Forward Revenue Growth

TOVX

20375.2%

ENSC

-45.7%

Profitability & performance

Gross Margin

TOVX

71.5%

ENSC

0.0%

ROE

TOVX

-9349.0%

ENSC

-37496.0%

FCF Yield %

ENSC

-116.0%

TOVX

-128.2%

52-Week Performance

TOVX

-51.8%

ENSC

-78.6%

Detailed metrics comparison

ENSC

Ensysce Biosciences Inc

TOVX

Theriva Biologics Inc

Market Cap

ENSC$8M

TOVX$10M

Enterprise Value

ENSC$7M

TOVX$275K

Price

ENSC$0.53

TOVX$0.22

P/E Ratio

ENSCN/A

TOVXN/A

P/S Ratio

ENSC1.72x

TOVX33.19x

EV/Sales

ENSC1.61x

TOVX0.92x

EV/EBITDA

ENSC0.00x

TOVX0.00x

P/B Ratio

ENSC2.39x

TOVX0.85x

P/FCF Ratio

ENSCN/A

TOVXN/A

EV/FCF

ENSC-0.81x

TOVX-0.02x

PEG Ratio

ENSCN/A

TOVXN/A

Forward P/E (NTM)

ENSCN/A

TOVXN/A

Forward P/S (NTM)

ENSCN/A

TOVXN/A

Revenue (TTM)

ENSC$5M

TOVX$300K

Revenue Growth (YoY)

ENSC-39.3%

TOVXN/A

Forward Rev Growth

ENSC-45.7%

TOVX20375.2%

Gross Margin (TTM)

ENSC0.0%

TOVX71.5%

Operating Margin (TTM)

ENSC0.0%

TOVX0.0%

EBITDA Margin (TTM)

ENSC-197.8%

TOVX-3940.7%

Net Margin (TTM)

ENSC-280.5%

TOVX-4376.0%

FCF Margin (TTM)

ENSC-199.5%

TOVX-4254.7%

Net Income (TTM)

ENSC$-13M

TOVX$-13M

FCF (TTM)

ENSC$-9M

TOVX$-13M

EPS (TTM)

ENSC-$0.97

TOVX-$0.29

ROE (TTM)

ENSC-37496.0%

TOVX-9349.0%

ROA (TTM)

ENSC-32046.0%

TOVX-3269.0%

ROIC (TTM)

ENSC-33277.0%

TOVX-8231.0%

Cash

ENSC$677K

TOVX$11M

Debt

ENSC$197K

TOVX$2M

Net Cash/Debt

ENSC$480K

TOVX$10M

Current Ratio (TTM)

ENSC0.70x

TOVX1.13x

Quick Ratio (TTM)

ENSC0.37x

TOVX1.09x

Debt/Equity (TTM)

ENSC0.10x

TOVX0.14x

Debt/Assets (TTM)

ENSC0.0%

TOVX0.0%

Interest Coverage (TTM)

ENSCN/A

TOVXN/A

Net Debt/EBITDA (TTM)

ENSC0.00x

TOVX0.00x

Beta

ENSC1.10

TOVX1.25

52W Performance

ENSC-78.6%

TOVX-51.8%

YTD Performance

ENSC-43.9%

TOVX-16.5%

% from 52W High

ENSC-80.8%

TOVX-74.8%

% from 52W Low

ENSC129.1%

TOVX35.6%

Asset Turnover (TTM)

ENSC1.14x

TOVX0.01x

FCF Yield (TTM)

ENSC-116.0%

TOVX-128.2%

Earnings Yield (TTM)

ENSC-163.1%

TOVX-131.8%

Dividend Yield (TTM)

ENSCN/A

TOVXN/A

Rule of 40

ENSC-238.8

TOVX-4,254.7

EV/GP/RG

ENSCN/A

TOVX0.00

Ticker research

View ENSC research View TOVX research

Metric	ENSC Ensysce Biosciences Inc	TOVX Theriva Biologics Inc
Market & Valuation
Market Cap	$8M	$10M
Enterprise Value	$7M	$275K
Price	$0.53	$0.22
P/E Ratio	N/A	N/A
P/S Ratio	1.72x	33.19x
EV/Sales	1.61x	0.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.39x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.81x	-0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$300K
Revenue Growth (YoY)	-39.3%	N/A
Forward Rev Growth	-45.7%	20375.2%
Profitability
Gross Margin (TTM)	0.0%	71.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-197.8%	-3940.7%
Net Margin (TTM)	-280.5%	-4376.0%
FCF Margin (TTM)	-199.5%	-4254.7%
Net Income (TTM)	$-13M	$-13M
FCF (TTM)	$-9M	$-13M
EPS (TTM)	-$0.97	-$0.29
ROE (TTM)	-37496.0%	-9349.0%
ROA (TTM)	-32046.0%	-3269.0%
ROIC (TTM)	-33277.0%	-8231.0%
Financial Health
Cash	$677K	$11M
Debt	$197K	$2M
Net Cash/Debt	$480K	$10M
Current Ratio (TTM)	0.70x	1.13x
Quick Ratio (TTM)	0.37x	1.09x
Debt/Equity (TTM)	0.10x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.10	1.25
52W Performance	-78.6%	-51.8%
YTD Performance	-43.9%	-16.5%
% from 52W High	-80.8%	-74.8%
% from 52W Low	129.1%	35.6%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.01x
FCF Yield (TTM)	-116.0%	-128.2%
Earnings Yield (TTM)	-163.1%	-131.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-238.8	-4,254.7
EV/GP/RG	N/A	0.00
Ticker research	View ENSC research	View TOVX research